News | June 27, 2007

Study Shows CAD for Breast MRI Improves Standardization, Analysis of Studies

June 28, 2007 - Confirma, developer of CADstream and market leader in computer-aided detection (CAD) for breast MRI, today announced research will be published in the July issue of the journal Radiology indicating that CAD for breast MRI may improve standardization and the analysis of benign and malignant lesions.
Teresa Williams, M.D., and colleagues at the Seattle Cancer Care Alliance and the University of Washington Medical Center did a retrospective examination of 154 breast lesions deemed suspicious by radiologists that were only visible on MRI and that had been biopsied under MRI guidance (‘Breast MR Imaging: Computer Aided Evaluation (CAE) Program for Discriminating Benign and Malignant Lesions’). They compared the findings and recommendations made by radiologists at the time to the findings obtained using CAD for breast MRI to evaluate studies.
The lesions in the study had been identified and biopsied during 2001-2004 from a study population of 125 women, age 27-86. The studies were processed using CADstream, version 3.0. CAD was used to analyze the breast tissue and mark areas where the MRI data curves were characteristic of abnormal lesions. Analysis of the tissue enhancement data as displayed in the CAD-processed images identified 38 of the 41 malignant lesions examined by radiologists using the software, according to researchers. Using the standardized CAD protocols and enhancement profiles, the radiologists noticed a reduction in their false positive rate. Dr. Williams was a medical resident in radiology at the Seattle Cancer Care Alliance (SCCA) when the research was done. She is now a fellow in pediatric radiology at Children’s Hospital and Regional Medical Center in Seattle.
“There are challenges associated with breast MRI and one is the time it takes to process and evaluate the many images acquired,” said Constance Lehman, M.D., corresponding author and director of radiology at the SCCA. “Computer software programs such as the one evaluated in our study can assist us in interpreting breast MRI scans more easily. Our study suggests that the information provided may improve our ability to distinguish between benign and malignant lesions.”
For more information: www.confirma.com

Related Content

MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
King's College London and NVIDIA Build U.K.'s First AI Platform for NHS Hospitals

King's College London will implement NVIDIA DGX-2 systems for AI research in the first phase of the project.

News | Artificial Intelligence | May 13, 2019
NVIDIA and King’s College London announced they are partnering to build an artificial intelligence (AI) platform that...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.